The Value Initiative is the Society of Nuclear Medicine and Molecular Imaging’s strategic vision and roadmap for working with industry and other partners to advance the crucial role of nuclear medicine, molecular imaging, and radiopharmaceutical therapy to the medical community, regulators, patients, and the public. 


Value Initiative In Action


CEO Summit and Panel Discussion: 
The Potential, Promise, and Value of Radiopharmaceutical Therapy

Watch this engaging discussion from the SNMMI 2021 Annual Meeting on system-wide ways to improve patient access and clinical outcomes. 
Meet the Panelists | Value Stream Mapping | Get Involved.

Value Initiative Newsletter: June 2022 Edition

In the June 2022 issue, we reflect on the past five years of the Value Initiative, and turn our focus to the future. Plus, read partner articles on HSA-I 131 Test For Blood Volume Shows Benefits in Heart Failure and Critical Care; Overcoming Lutetium-177 Production and Supply Challenges; PYLARIFY® (piflufolastat F 18) Injection and PYLARIFY AI™: From Innovation and Regulatory Submission to FDA Approval and Market Adoption; Capintec and Biodex Brands Merge Under Mirion Technologies; a Focus on Actinium-225; What’s the Difference Between Increased Access and Equal Access When It Comes to PET/CT?; How Imaging Advancements Are Helping Cardiologists Prevent Unnecessary Cardiac Catheterizations; A New Process for Attenuation Correction of Myocardial Perfusion Images: digital SPECT scanner technology with Deep Learning advanced applications; and Artificial Intelligence Applications for PET Image Reconstruction. 

Download the June 2022 Value Initiative Newsletter.

Learn more about our Value Initiative Industry Alliance Member Companies.

Leadership Circle             

                   


Visionary Member  


Principal Member                 

                           

            


Corporate Member